Cholestyramine clinical pharmacology: Difference between revisions

Jump to navigation Jump to search
(Created page with " __NOTOC__ {{Cholestyramine}} {{CMG}}; {{AE}} {{SS}} ==Clinical Pharmacology== Cholesterol is probably the sole precursor of bile acids. During normal digestion, bile ...")
 
(Redirected page to Cholestyramine)
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
 
#REDIRECT [[Cholestyramine]]
__NOTOC__
{{Cholestyramine}}
{{CMG}}; {{AE}} {{SS}}
 
==Clinical Pharmacology==
 
Cholesterol is probably the sole precursor of [[bile acid]]s. During normal digestion, [[bile acid]]s are secreted into the intestines. A major portion of the [[bile acid]]s is absorbed from the intestinal tract and returned to the liver via the [[enterohepatic circulation]]. Only very small amounts of [[bile acid]]s are found in normal serum.
 
Cholestyramine resin adsorbs and combines with the [[bile acid]]s in the intestine to form an insoluble complex which is excreted in the feces. This results in a partial removal of [[bile acid]]s from the enterohepatic circulation by preventing their absorption.
 
The increased fecal loss of [[bile acid]]s due to cholestyramine resin administration leads to an increased oxidation of cholesterol to [[bile acid]]s, a decrease in beta lipoprotein or low-density lipoprotein plasma levels and a decrease in serum cholesterol levels. Although in man, cholestyramine resin produces an increase in hepatic synthesis of cholesterol, plasma cholesterol levels fall.
 
In patients with partial biliary obstruction, the reduction of serum [[bile acid]] levels by cholestyramine resin reduces excess [[bile acid]]s deposited in the dermal tissue with resultant decrease in pruritus.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = PREVALITE (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [UPSHER-SMITH LABORATORIES INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd434ef8-8af3-434c-a0a0-9a0b18459ba0 | publisher =  | date =  | accessdate = 10 February 2014 }}</ref>
 
==References==
 
{{Reflist|2}}
 
{{Lipid modifying agents}}
 
[[Category:Hepatology]]
[[Category:[[bile acid]] sequestrants]]
[[Category:Cardiovasuclar Drugs]]
[[Category:Drugs]]

Latest revision as of 13:53, 21 July 2014

Redirect to: